Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Keith Kentala of AbbVie Contract Manufacturing offers his thoughts on the value CDMOs bring to their customers
January 26, 2018
By: Keith Kentala
Vice President, Commercial Operations, AbbVie Contract Manufacturing
What value does a top pharmaceutical contract manufacturer bring to its customers? There are many important ways that a contract development and manufacturing organization (CDMO) brings value to its pharmaceutical partners. Perhaps most important is being a driver in moving a product forward, not an anchor that weighs the process down or holds it back. The outsourcing partner must be able to get the product over the finish line—whether that’s clinical trial batches, development work, or commercial manufacture—in line with the sponsor’s expectations. You don’t ever want the CMC (chemistry, manufacturing, and controls) portion of your regulatory filing to hold up approval of the product. So a clean CMC from the work your CDMO provides is of tremendous value in getting patients the drugs they need on time, as well as contributing to the pharmaceutical company’s overall financial goals. Reputation CDMOs are entrusted with protecting their pharmaceutical partner’s brand reputations. That means CDMOs must have solid reputations themselves for consistently high-quality products and processes, great technology, and expertise. This is most reliably learned through word-of-mouth, and also the CDMO’s regulatory filings and products on the market. To have a reputable and industry-respected CDMO is of tremendous value. It also helps tremendously when regulators look at your filings; they want to know who’s manufacturing product and can be reassured by the manufacturer’s reputation. Resources CDMOs add value when they have the resources needed by pharma, so pharma doesn’t have to invest its capital. Does the CDMO have the technologies and equipment necessary for the job? For example, biologics facilities are expensive to construct, so you can preserve your capital for clinical development and trials by outsourcing to a well-equipped, cost-efficient, biologics-capable CDMO. Expertise Similar to the more tangible technology and equipment lists, experience and expertise add value of a softer, but no less important, nature. It’s valuable when a CDMO can save you time, not to mention aggravation, because they have overcome challenges that are similar to one you may be having. Or when it contributes scientific, manufacturing, and business/operational expertise that keeps your project on track. Scale Value is also derived when a CDMO can deliver what you need, and only what you need, when you need it. We have clients who just need us to manufacture clinical trial batches, but also those who aren’t ready for manufacturing and need development work. We also have clients who transition with us from clinical to commercial manufacturing. Meeting their exact need can be critical to helping clients keep their project budgets and regulatory timelines, on track. Relationship An essential value is the relationship between the CDMO and the pharmaceutical sponsor. How do you know you’re important to the CDMO? How are they are going to prioritize your needs? Certainly the contract between the two parties protects interests, but the relationship is the additive that makes the engagement work well. There is tremendous value when you have confidence in the organizational capabilities and commitment of your CDMO to have a “customer first” mentality. The old adage is certainly true, if you don’t take care of your customers, someone else will. Keith Kentala is vice president of commercial operations at AbbVie Contract Manufacturing. Click here to learn more about the company.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !